BioAdvance
  • Home
  • About
  • Team
  • Portfolio
  • News
  • FAQ
  • Contact


News

Dec 01, 2007

By bioadvance


BioAdvance Newsletter Winter 2007
Read more here

Aug 02, 2007

By bioadvance


Melior Discovery Enters New Pharmaceutical Collaboration
Read more here

Apr 09, 2007

By bioadvance


Melior Enters Research Collaboration with Pfizer
Read more here

Apr 01, 2007

By bioadvance


New Funding Model for Start-Ups
Read more here

Current News

  • VenatoRx Receives $9.4 Million from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Drug Resistant Bacteria
  • VenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer
  • Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program
  • Dr. Ottavio Vitolo Appointed Executive Clinical Advisor at Relmada Therapeutics
  • Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer

Archive

  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

© 2013-2017 BioAdvance. All rights reserved.